Dr. Diana Driscoll and Dr. Clair Francomano present an evaluation of molecular, chemical and cellular changes that occur in the multiple sclerosis and Ehlers-Danlos patient leading to left ventricular diastolic dysfunction. Such effects may be systemic, leading to potential causes of restenosis and new treatment options to reduce such systemic chemical changes.